Danny Edwards joins a seminar on governance and corruption at University of Toronto

This event will provide health care professionals and researchers with the opportunity to gain a better understanding of how corruption and lack of good governance can have an impact on pharmaceutical services and how to counter vulnerabilities within the sector.

Each Access to Medicine Index is the product of a two-year process known as the ‘Index cycle’, which begins with a review of the Index methodology that is now underway. Currently, the Index team is reviewing the Index methodology drawing on feedback from independent experts and stakeholders active in access to medicine. The aim is to align the methodology with changes in access-to-medicine priorities and expectations as to how pharmaceutical companies can make their products available, accessible and affordable to people living in developing countries. The methodology report will be published at the beginning of October 2017.